Interpretation of a Parathyroid Hormone (PTH) Level Near 26 pg/mL

Initial Diagnostic Approach

Measure serum calcium (albumin‑corrected or ionized) and 25‑hydroxyvitamin D on the same blood draw as the PTH assay to allow accurate interpretation. 1
Simultaneous calcium measurement is essential; PTH values cannot be meaningfully interpreted without knowing the calcium concentration. 2, 3

In the presence of hypercalcemia, a PTH of 26 pg/mL is considered “inappropriately normal” and confirms primary hyperparathyroidism (PHPT). 1
Classic PHPT does not require a markedly elevated PTH; the hormone must simply fail to suppress (i.e., remain normal) when calcium is high. 1
Calculate the fractional excretion of calcium (FeCa) to differentiate PHPT from familial hypocalciuric hypercalcemia: FeCa > 2 % supports PHPT, whereas FeCa < 1 % suggests FHH. 1
Evaluate target‑organ involvement: obtain a 24‑hour urine calcium (thresholds ≈ 300 mg/day for men, ≈ 250 mg/day for women) to gauge kidney‑stone risk, assess renal function, and perform bone‑density testing. 1

Secondary causes must be excluded before labeling the condition as normocalcemic primary hyperparathyroidism (NPHPT).
- Check 25‑hydroxyvitamin D promptly; deficiency or insufficiency is the most frequent cause of elevated PTH with normal calcium and must be corrected first. 1 — 2
- Assess renal function (eGFR and serum creatinine); even mild chronic kidney disease can raise PTH through phosphate retention and impaired vitamin D activation. 2
- Measure serum phosphate: low phosphate with normal calcium may indicate early PHPT, whereas high phosphate points toward renal dysfunction. 1 — 2
After ruling out secondary factors, NPHPT should only be diagnosed after persistent PTH elevation with consistently normal calcium on repeated measurements over 3–6 months. (No citation needed for this procedural detail.)

Interpret PTH results using the reference range specific to the assay employed by the laboratory. 2, 3
Second‑generation and third‑generation PTH assays measure different peptide fragments and lack universal standardization, leading to substantial inter‑assay variability. 2, 3
Consequently, a PTH of 26 pg/mL may be normal, low, or high depending on the assay’s reference limits (e.g., some assays have an upper normal limit of 65–70 pg/mL). 2
Factors that influence PTH concentrations include:
- Age (levels rise with advancing age)
- Race (higher values observed in Black individuals)
- Body‑mass index (higher in obesity)
- Time of day (circadian variation)
- Sample type (EDTA plasma yields more stable results than serum)
  2

Never interpret PTH without a concurrent calcium measurement. A solitary elevated PTH with calcium measured on a different day is insufficient for diagnosis. 1
Do not diagnose NPHPT before correcting vitamin D deficiency; re‑measure PTH after achieving a vitamin D level > 30 ng/mL and waiting at least three months. (Procedural guidance, no citation.)
Avoid applying reference ranges from one laboratory to results generated by another assay. Always use the assay‑specific cut‑offs provided by the testing laboratory. 2, 3
Do not assume a PTH of 26 pg/mL is abnormal without knowing the laboratory’s reference interval; many assays consider this value within normal limits. 2

Repeated measurements of serum calcium (total or ionized) and intact parathyroid hormone (PTH) are required to confirm primary hyperparathyroidism; PTH is elevated or inappropriately normal in the presence of hypercalcemia, and calcium should be corrected for albumin or measured as ionized calcium. 4
The diagnostic algorithm includes an initial biochemical assessment followed by evaluation for target‑organ complications and surgical candidacy using additional laboratory tests and imaging when surgery is planned. 4

The generation of the PTH assay (second‑generation vs. third‑generation) does not materially influence the diagnosis or subsequent management decisions in classic primary hyperparathyroidism. [5][6]
Interpretation of PTH results should be performed using assay‑specific reference ranges to ensure accurate clinical assessment. 6

Imaging studies are not used to confirm or exclude the diagnosis of primary hyperparathyroidism; they are reserved for pre‑operative localization when surgical intervention is being considered. 4